Oncology

Jane Armes discusses the value of molecular subtyping and targeted therapies in triple-negative breast cancer

Liquid biopsy has shown promise as a rapid, minimally invasive way to profile tumors – but are commercially available tests accurate and consistent?

The use of saliva as a diagnostic fluid seems an attractive option – especially now that research reveals circulating tumor DNA in the fluid

The FLEX breast cancer registry intends to collect complete information on 10,000 patients over the course of 10 years

A pioneer of epigenetics discusses his career and what he has learned from a fascinating journey through medicine

Newly discovered genetic alterations could indicate whether treatment or active surveillance is the best option for low-risk prostate cancer patients

Luxembourg’s new molecular diagnostics program aims to establish the value of such analyses as a part of routine cancer care

To harness liquid biopsy’s many advantages, it’s vital to ensure appropriate testing – and cfDNA synthetic plasma reference standards can help

Differences in bacterial diversity in the gut could be used to identify patients with Barrett’s esophagus and esophageal cancer

We round up the latest news in pathology and laboratory medicine with these bite-sized stories